We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
-0.99%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$83.4B
AUM Growth
+$43.7B
(+110%)
Cap. Flow
+$37.8B
Cap. Flow
% of AUM
45.4%
Top 10 Holdings %
Top 10 Hldgs %
20.06%
Holding
3,019
New
106
Increased
1,341
Reduced
840
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$1.49B |
| 4 |
Amazon
AMZN
|
+$1.06B |
| 5 |
Broadcom
AVGO
|
+$985M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$290M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$245M |
| 3 |
L3Harris
LHX
|
+$162M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$143M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.33% |
| 2 | Healthcare | 11.39% |
| 3 | Consumer Discretionary | 9.69% |
| 4 | Financials | 7.31% |
| 5 | Industrials | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
BridgeBio Pharma
BBIO
$15.9B
| $413K | ﹤0.01% |
41,578
| – | – |
|
2002
Remitly
RELY
$5.39B
| $413K | ﹤0.01% |
37,118
+5,630
| +18% | +$58.7K |
|
|
PRA
2003
DELISTED
ProAssurance
PRA
| $413K | ﹤0.01% |
21,155
-6,995
| -25% | -$154K |
|
|
CSR
2004
Centerspace
CSR
$939M
| $412K | ﹤0.01% |
6,123
+273
| +5% | +$21.7K |
|
|
YMAB
2005
DELISTED
Y-mAbs Therapeutics
YMAB
| $410K | ﹤0.01% |
28,452
| – | – |
|
2006
Azenta
AZTA
$1.49B
| $409K | ﹤0.01% |
9,534
-312
| -3% | -$18.6K |
|
2007
Axogen
AXGN
$2.58B
| $408K | ﹤0.01% |
34,257
+1,293
| +4% | +$12.9K |
|
2008
FIGS
FIGS
$2.47B
| $408K | ﹤0.01% |
49,444
-41,988
| -46% | -$447K |
|
2009
Lazard
LAZ
$4.43B
| $408K | ﹤0.01% |
12,812
-10,778
| -46% | -$388K |
|
2010
SI-BONE Inc
SIBN
$849M
| $407K | ﹤0.01% |
23,323
-3,063
| -12% | -$49K |
|
2011
Emergent Biosolutions
EBS
$230M
| $405K | ﹤0.01% |
19,305
| – | – |
|
2012
Crinetics Pharmaceuticals
CRNX
$8.96B
| $405K | ﹤0.01% |
20,606
+746
| +4% | +$15.2K |
|
|
PRO
2013
DELISTED
PROS Holdings
PRO
| $405K | ﹤0.01% |
16,382
| – | – |
|
|
NKLA
2014
DELISTED
Nikola Corporation Common Stock
NKLA
| $404K | ﹤0.01% |
3,829
+150
| +4% | +$25.4K |
|
|
CUTR
2015
DELISTED
Cutera, Inc.
CUTR
| $404K | ﹤0.01% |
8,859
-8,764
| -50% | -$400K |
|
2016
Credo Technology Group
CRDO
$49.6B
| $404K | ﹤0.01% |
+36,683
| New | +$484K |
|
|
VRE
2017
DELISTED
Veris Residential
VRE
| $402K | ﹤0.01% |
35,388
| – | – |
|
2018
SFL Corp
SFL
$1.61B
| $402K | ﹤0.01% |
44,129
+1,844
| +4% | +$18.7K |
|
2019
SSR Mining
SSRM
$6.49B
| $401K | ﹤0.01% |
27,293
-672
| -2% | -$10.1K |
|
2020
Brighthouse Financial
BHF
$3.42B
| $398K | ﹤0.01% |
9,177
-713
| -7% | -$32.5K |
|
2021
Antero Midstream
AM
$10.5B
| $397K | ﹤0.01% |
43,286
-1,675
| -4% | -$16.5K |
|
2022
Mitek Systems
MITK
$853M
| $396K | ﹤0.01% |
43,271
+9
| +0% | +$90 |
|
|
MRC
2023
DELISTED
MRC Global
MRC
| $396K | ﹤0.01% |
55,077
-68
| -0.1% | -$670 |
|
2024
Dime Commercial Bancshares
DCOM
$1.82B
| $396K | ﹤0.01% |
13,513
| – | – |
|
2025
Aurinia Pharmaceuticals
AUPH
$2.02B
| $395K | ﹤0.01% |
52,480
+1,751
| +3% | +$15.2K |
|
Similar funds
VOYA Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, VOYA Investment Management held 3,019 positions worth $83.4B, up 110% from $39.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
VOYA Investment Management deployed $37.8B of net new capital in Q3 2022, opening 106 new positions and adding to 1,341 existing holdings. Its largest new stake was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B: 364,410 shares worth $491M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was L3Harris, an estimated $162M trimmed.
- VOYA Investment Management's largest Q3 2022 buy was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B: 364,410 shares worth $491M.
- VOYA Investment Management added most to Apple in Q3 2022, an estimated $1.85B increase.
- VOYA Investment Management's biggest Q3 2022 reduction was L3Harris, cutting an estimated $162M.
- VOYA Investment Management fully exited iShares MSCI Japan ETF in Q3 2022, selling an estimated $290M.
- VOYA Investment Management's ten largest holdings make up 20% of its $83.4B portfolio in Q3 2022.
- VOYA Investment Management opened 106 new positions and closed 80 in Q3 2022.
- VOYA Investment Management's portfolio value rose 110% quarter-over-quarter to $83.4B.
Based on VOYA Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.